Epineuron wins FDA clearance for nerve stimulator
May 13, 2026
Epineuron announced today that it received FDA 510(k) clearance for its Evala nerve stimulator technology.
Epineuron announced today that it received FDA 510(k) clearance for its Evala nerve stimulator technology.
The US Food and Drug Administration (FDA) has cleared Bayesian Health’s continuous artificial intelligence (AI)-driven sepsis monitor, making the device the first of its kind to achieve this milestone.
Siemens Healthineers announced today that the FDA cleared six new systems within its Artis interventional imaging portfolio.
Diabeloop announced today that it received CE mark approval for its latest automated insulin delivery (AID) platform, DBLG2.
Corvention announced today that it received FDA 510(k) clearance for its KardiaPSI balloon catheter device.
Handheld fingertip device delivers clinical-grade readings — no cuff, no calibration, no compromise.
The NMPA designation advances NHWD-870 HCI, an oral BET inhibitor for advanced thoracic NUT carcinoma, following Phase II data showing anti-tumour activity and survival benefit in a rare, aggressive cancer with limited treatment options.
The approval of Bright Uro’s Glean abdominal sensor advances the capabilities of its broader Glean urodynamics system that gained FDA approval in March 2025.
With FDA clearance in hand, Rivanna highlighted that it will accelerate the development of further AI capabilities for the Accuro XV system.
FORT LAUDERDALE, Fla., May 7, 2026 /PRNewswire/ — Spinal Resources, Inc., a developer of advanced spinal stabilization technologies, today announced the issuance of U.S. Patent No. 12,611,231, “Spinal Rod and Systems Thereof”.